Illumina dips 4% as SEC launches Grail merger probe



Shares of American biotechnology firm Illumina Inc. slid 4% on Friday after revealing that the United States Securities and Exchange Commission (SEC) launched a probe into its $8 billion acquisition a…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento